Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Current price $34.84
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Jul 21, 26 | Canaccord Genuity |
| maintain |
| Hold |
| Hold |
| May 6, 26 | Canaccord Genuity | maintain | Hold | Hold |
| Dec 17, 25 | Canaccord Genuity | maintain | Hold | Hold |
| Aug 7, 25 | Canaccord Genuity | maintain | Hold | Hold |
| May 15, 25 | Canaccord Genuity | maintain | Hold | Hold |
| Feb 26, 25 | Canaccord Genuity | maintain | Hold | Hold |
| Feb 6, 25 | JMP Securities | maintain | Market Perform | Market Perform |
| Oct 23, 24 | Barclays | maintain | Overweight | Overweight |
| Oct 23, 24 | Canaccord Genuity | maintain | Hold | Hold |
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-26
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 73.81 | Oscillator | Sell |
| Stochastic %K (14, 3, 3) | 92.68 | Oscillator | Sell |
| Williams %R (14) | -18.13 | Oscillator | Sell |
| MACD (12, 26, 9) | 1.28 (Hist 0.13) | Oscillator | Strong Buy |
| Average Directional Index (14) | 50.24 (+DI 39.7 / -DI 9.6) | Trend | Strong Buy |
| EMA 20 | 32.88 | MA | Strong Buy |
| SMA 20 | 32.70 | MA | Strong Buy |
| EMA 50 | 31.02 | MA | Strong Buy |
| SMA 50 | 30.50 | MA | Strong Buy |
| SMA 200 | 25.34 | MA | Strong Buy |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 23, 26 | Rebrovick Linda | director | S-Sale | 12,000 @ $35.00 | $420.0K |
| Sep 29, 26 | Roberts Scott Alexander | officer: CFO and SVP | M-Exempt | 1,564 | — |
| Sep 29, 26 | Roberts Scott Alexander | officer: CFO and SVP | F-InKind | 381 @ $29.10 | $11.09K |
| Sep 29, 26 | Roberts Scott Alexander | officer: CFO and SVP | M-Exempt | 310 | — |
| Sep 29, 26 | Roberts Scott Alexander | officer: CFO and SVP | M-Exempt | 410 | — |
| Sep 29, 26 | Roberts Scott Alexander | officer: CFO and SVP | M-Exempt | 844 | — |
| Sep 29, 26 | O'Hara Kevin P | officer: Executive Vice President | M-Exempt | 1,642 | — |
| Sep 29, 26 | O'Hara Kevin P | officer: Executive Vice President | F-InKind | 400 @ $29.10 | $11.64K |
Stock news · updated daily
NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthStream, Inc. (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, announced today that it will host a conference call and webcast to discuss its third quarter 2026 financial results on Tuesday, November 3, 2026. The Company's financial results for the third quarter 2026, ended Sept. 30, 2026, will be released after the routine time for the close of the market on Monday, November 2, 2026. HealthStream's third.
HealthStream (NASDAQ: HSTM - Get Free Report) and Weave Communications (NYSE: WEAV - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends. Insider and Institutional Ownership 69.6% of HealthStream shares
Shares of HealthStream, Inc. (NASDAQ: HSTM - Get Free Report) reached a new 52-week high during trading on Monday. The company traded as high as $31.37 and last traded at $31.4540, with a volume of 6598 shares trading hands. The stock had previously closed at $30.36. Analyst Ratings Changes HSTM has been the subject of several
HealthStream, Inc. (NASDAQ: HSTM - Get Free Report) CEO Robert Frist, Jr. sold 144,068 shares of the company's stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $29.50, for a total transaction of $4,250,006.00. Following the transaction, the chief executive officer directly owned 3,907,038 shares of the company's
NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthStream, Inc. (Nasdaq: HSTM) (the “Company”), a leading healthcare technology platform company for clinical workforce solutions, today announced the completion of a private placement transaction through which WJRJJ Ventures, LLC (“WJRJJ”) acquired a total of 1.5 million shares of the Company's common stock. In this transaction, the Company issued 1,355,932 shares of common stock to WJRJJ for approximately $40 million in cash at a purchase price of $29.50.
NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthStream (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, today defined the Enterprise Clinical Workforce Platform (ECWP), establishing a new enterprise category for healthcare built on a single, verified record for every clinician. For decades, health systems have standardized on two enterprise systems: the electronic health record (EHR) for the clinical record and enterprise resource planning (ERP) for fi.
HealthStream (NASDAQ: HSTM - Get Free Report) and Definitive Healthcare (NASDAQ: DH - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, dividends, earnings and risk. Earnings and Valuation This table compares HealthStream and
INDIANAPOLIS--(BUSINESS WIRE)--Humana Healthy Horizons in Indiana Collaborates with HealthStream to Expand and Strengthen Home Care Workforce.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 3, 2026 | 0.17 | 0.23 | Beat 38.6% | $83.73M |
| May 4, 2026 | 0.16 | 0.20 | Beat 25.0% | $81.20M |
| Feb 23, 2026 | 0.16 | 0.09 | Miss -43.8% | $79.71M |
| Nov 3, 2025 | 0.17 | 0.20 | Beat 17.6% | $76.47M |
| Aug 4, 2025 | 0.16 | 0.18 | Beat 12.5% | $74.40M |
| May 5, 2025 | 0.16 | 0.14 | Miss -12.5% | $73.48M |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 4 | Oct 23, 2026 | 2026-10-23 16:54:10 | View |
| 4 | Sep 29, 2026 | 2026-09-29 17:38:32 | View |
| 4 | Sep 29, 2026 | 2026-09-29 17:37:32 | View |
| 4 | Sep 29, 2026 | 2026-09-29 17:35:35 | View |
| 4 | Sep 29, 2026 | 2026-09-29 17:34:17 | View |
| 4 | Sep 29, 2026 | 2026-09-29 17:33:04 | View |
| 4 | Sep 29, 2026 | 2026-09-29 17:31:09 | View |
| 4 | Sep 29, 2026 | 2026-09-29 17:29:06 | View |
| 4 | Sep 29, 2026 | 2026-09-29 17:27:38 | View |
| 8-K | Sep 23, 2026 | 2026-09-23 16:15:07 | View |
Proxy statement (DEF 14A) disclosures
FY2025 · 10-K disclosure
TTM vs. 5-year historical average (annual ratios)
| Metric | HSTM | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 48.7x | 68.5x · sector 20.7x | Elevated |
| Forward P/E (FY26E) | 47.3x | EPS est. 0.74 | In line |
| Price / Book | 2.9x | 2.4x | Elevated |
| Price / Sales | 3.3x | 2.9x | In line |
| EV / EBITDA | 14.4x | 13.9x | In line |
| Return on equity | 6.0% | — | Weak |
| Gross margin | 65.1% | 65.5% | In line |
| Debt / Equity | 0.04 | 0.06 | Conservative |
| Piotroski / Altman Z | 7/9 | Z 5.08 | Safe zone |
Discounted cash flow model